Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 205470
Company: SUN PHARMA CANADA

Products on ANDA 205470

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
ACYCLOVIR	ACYCLOVIR	5%	CREAM;TOPICAL	Prescription	AB	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 205470

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
06/12/2024	ORIG-1	Approval		STANDARD	Letter (PDF)	Label is not available on this site.	https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/205470Orig1s000TAltr.pdf

Therapeutic Equivalents for ANDA 205470

ACYCLOVIR

CREAM;TOPICAL; 5%
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
ACYCLOVIR	ACYCLOVIR	5%	CREAM;TOPICAL	Prescription	No	AB	212361	ALEMBIC
ACYCLOVIR	ACYCLOVIR	5%	CREAM;TOPICAL	Prescription	No	AB	208766	AMNEAL
ACYCLOVIR	ACYCLOVIR	5%	CREAM;TOPICAL	Prescription	No	AB	208702	PADAGIS ISRAEL
ACYCLOVIR	ACYCLOVIR	5%	CREAM;TOPICAL	Prescription	No	AB	205470	SUN PHARMA CANADA
ZOVIRAX	ACYCLOVIR	5%	CREAM;TOPICAL	Prescription	Yes	AB	021478	BAUSCH